Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 1 4Phase 2 2

Status

Terminated 5Withdrawn 1

Sponsor Class

INDUSTRY 6

Study Type

Interventional 6

Sponsor

Conditions

Leiomyoma 6Menorrhagia 3

Interventions

Carboplatin 315Paclitaxel 303Cisplatin 250Docetaxel 238pembrolizumab 230Gemcitabine 214Pemetrexed 158Capecitabine 147Rituximab 144Bevacizumab 142Dexamethasone 125Fluorouracil 121Cyclophosphamide 102Trastuzumab 100Doxorubicin 96Nivolumab 93Prednisone 92Oxaliplatin 90atezolizumab 75Leucovorin 72durvalumab 69130-nm albumin-bound paclitaxel 68Injections 66Lenalidomide 63Irinotecan 62Bortezomib 56Letrozole 54Topotecan 53Fulvestrant 53Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × INDUSTRY × vilaprisan × Clear all
NCT03194646 2025-07-28

ASTEROID 6

Bayer

Phase 3 Terminated
1,272 enrolled 16 charts

Leiomyoma

NCT03240523 2024-10-18

ASTEROID 5

Bayer

Phase 3 Terminated
766 enrolled

Leiomyoma

NCT03400943 2023-05-03

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3)

Bayer

Phase 3 Terminated
93 enrolled 19 charts

Leiomyoma, Menorrhagia

NCT03476928 2022-07-08

ASTEROID 8

Bayer

Phase 3 Terminated
153 enrolled

Leiomyoma, Menorrhagia

NCT03400956 2022-06-30

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)

Bayer

Phase 3 Terminated
103 enrolled 18 charts

Leiomyoma, Menorrhagia

NCT03699176 2020-01-18

ASTEROID 7

Bayer

Phase 3 Withdrawn

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡